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Abstract
BACKGROUND: Myocarditis is most often caused by Coxackie
B virus, influenza viruses, and echoviruses. It is usually self-re-
stricting and ending in full recovery, but in some patients the
infection leads to congestive cardiomyopathy. It is difficult to iden-
tify patients with myocarditis using clinical criteria, laboratory tests,
ECG and ultrasonography, and currently a myocardial biopsy is
required to establish the diagnosis. The risk of complications,
sampling error and costs of this procedure underline the need of
non-invasive but sensitive methods of imaging. Several radiop-
harmaceuticals have been used so far to confirm inflammation:
67Ga, 99mTc-nanocolloids and 111In-leucocytes. Scintigraphy with
radiolabeled autologous white blood cells (WBCs) is considered
a very useful method in identifying sources of inflammation but
is difficult to perform and time-consuming.
AIMS: The aim of our study was to investigate whether scinti-
graphy with 99mTc-Anti-Granulocyte BW 250/183 antibody is
a valuable diagnostic method in evaluating focal and diffuse
inflammation of the heart and could therefore be suggested for
use in screening for acute myocarditis.
MATERIAL AND METHODS: A two dimensional scintigraphy and
SPECT mode of heart imaging with the use of 99mTc-Anti-Gran-
ulocyte antibody (740 MBq) was performed on 14 subjects
(11 males and 3 females) aged 25–60 years with a positive my-
ocardial biopsy confirming an inflammatory process in the my-
ocardium. After i.v. administration of the tracer a 1 minute se-
ries of planar scans was performed within the first 60 minutes.
Delayed static scans were performed at 1, 2, 4 and 24 hours.
RESULTS: The scintigraphic scans revealed the uptake of the
tracer in the heart area in 13 patients, confirming active inflamma-
tory process. Follow-up scintigraphy was performed 3–5 months
after the first study, when the control myocardial biopsy was
negative. The results of the study showed the concordance
between myocardial biopsy and scintigraphy results in patients
with an inflammatory process in the heart.
CONCLUSIONS: Scintigraphy with the use of 99mTc-Anti-Gra-
nulocyte seems to be a useful diagnostic method in evaluating
patients with suspected myocarditis, but further studies are
needed to establish its sensitivity and specificity.
Keywords: 99mTc-Anti-Granulocyte BW 250/183 antibody,
myocardial inflammation, myocarditis, scintigraphy,
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Introduction
Definite histopathologic evidence of acute myocardial inflam-
mation is obtained in only 10% of patients presenting signs and
symptoms of unexplained cardiomyopathy [1]. Clinical diagnosis
of myocarditis is usually very difficult due to varying clinical pre-
sentation ranging from asymptomatic cases to fatal acute heart
insufficiency. Diminished physical performance, fatigue, palpita-
tions and shortness of breath predominate, but in some patients
malignant ventricular arrhythmias might be the leading symptoms.
Enzyme assays as well as immunologic tests have proved a weak
correlation with the disease’s severity and may even be negative
in some cases. The lack of a definite clinical picture of the di-
sease, non-specific laboratory tests and non-specific electrocar-
diographic and echocardiographic findings obscure the diagnosis.
166
Nuclear Medicine Review 2004, Vol. 7, No. 2
www.nmr.viamedica.pl
Short
communi-
cations
Viral infections are the main etiological factors in Europe and
North America [2], and include Coxackie viruses, adenovirus and
echovirus, while in South America the disease is most often caused
by parasite infection – known as Chagas disease. Acute myo-
carditis infrequently develops during viral epidemics. Inflammato-
ry process may involve cardiomyocytes, interstitial tissue and co-
nnective tissue at varying degrees, and rarely the large epicardial
vessels. Heart involvement in the inflammatory process is most
often focal, but may also be heterogeneous or diffuse. In most
causes it is a self-restricting process ending in full recovery.
It remains unclear why in some patients the infection leads to con-
gestive cardiomyopathy.
There is a hypothesis that the destruction and fibrosis of the
myocardium are a consequence of a immunological reaction to
viral particles. The reaction is caused by cross-reaction of antigen
structures of viruses and cells of the myocardium. The presence
of AMLA-IgM, ASA-IgM, and IgM in a myocardial biopsy sample
was shown in 70–80% of cases of acute myocardial inflammation.
Viruses are usually eliminated from cardiac tissue within 2–3 weeks
[3], but incomplete virus elimination results in persistent infla-
mmation that further stimulates an autoimmune process leading
to the progressive destruction of cardiomyocytes and the develop-
ment of congestive heart disease [4, 5].
Currently, a myocardial biopsy is required to establish the
diagnosis of acute myocarditis. This biopsy is an invasive proce-
dure that carries a certain risk of complication [6], and the cost of
the procedure is relatively high. Therefore, a new diagnostic tech-
nique for the early and non-invasive evaluation of myocarditis has
been long awaited. Current methods of myocardial biopsy may
be inadequate to detect the presence of inflammation, and the
results may be false negative, especially in cases of focal disease,
which appears to be more frequent than disperse inflammation.
Since sampling errors makes the test insensitive in such cases,
additional methods of evaluation are needed.
For many years, new sensitive methods of non-invasive de-
tection of inflammatory processes in the heart have been sought
and the techniques of its scintigraphic detection have been im-
proved [7, 8]. All inflammatory processes typically involve in-
creased blood supply, the leakage of fluid, small molecules and
proteins, and the infiltration of cells. Scintigraphic imaging of in-
flammation can be achieved in various ways, depending on which
aspect of the inflammatory process is to be addressed. Non-spe-
cific markers (e.g. radiolabeled non-specific immunoglobulins or
liposomes) accumulate due to locally enhanced blood supply and
vascular permeability. It should be noted that all radiopharma-
ceuticals tend to accumulate to some extent in such non-specific
ways. Specific markers of inflammation are obtained by radiola-
beling white blood cells isolated from the patient (which are fur-
ther reinjected) or by directly targeting leukocyte antigens or re-
ceptors.
For almost two decades, 111In has been the primary radionu-
clide used to label leukocytes for imaging areas of suspected in-
flammation. The diagnostic procedure using 99mTc radiolabeled
autologous blood cells (WBCs) is laborious and time-consuming.
Isotope imaging studies with the use of labeled antigranulocyte
monoclonal antibodies that are now available due to the rapid
development of immunological technologies hold the promise of
the non-invasive highly sensitive diagnosis of myocarditis. The
techniques for radiolabeling with 99mTc have become available [8, 9]
and are being more widely used in many centres: e.g. 99mTc-la-
beled monoclonal antibody Fab’-fragments [99mTc-anti-NCA-90
IMMU-MN3; LeukoScan®] or 99mTc-labeled monoclonal specific an-
tibody [99mTc-anti-CEA-NCA-95 BW 250/183; Anti-Granulocyte], which
we used in our study. In addition, a wide variety of peptides binding
to leukocyte receptors have been investigated, including cytokines
such as interleukin-1, interleukin-2, interleukin-8, derivatives of plate-
let factor 4, and complementary factors such as C5a [9].
The aim of the study was to investigate whether scintigraphy
with 99mTc-Anti-Granulocyte is a valuable diagnostic method in
evaluating focal and diffuse inflammation of the heart and there-
fore could be suggested in screening for acute myocarditis.
An additional aim of the study was to establish the optimal acqui-
sition procedure in the studies using 99mTc-Anti-Granulocyte which
is a new tracer employed in the scintigraphic evaluation of the
heart.
Material and methods
Heart scintigraphy with the use of 99mTc-Anti-Granulocyte BW
250/183 antibody, manufactured by CIS BIO INTERNATIONAL (Gif-
sur-Yvette, France), was performed in 14 subjects (11 males and
3 females) aged 25–60 years (mean 44.8 ± 10.7 years) with
a positive myocardial biopsy confirming an inflammatory process
in the heart. None of the patients studied received any anti-infla-
mmatory treatment prior to the scintigraphic assessment. All of the
patients included in the study presented signs and symptoms
of heart insufficiency and they were hospitalised in the Depart-
ment of Cardiology due to aggravating heart failure. Left ventricu-
lar ejection fraction (LVEF) was 14–42% (mean 25% ± 10.4%) at
the beginning of the study. General hypokinesis of the heart was
found using echocardiography. Coxackie virus infection was con-
firmed in 8 of the patients by serological studies.
Histopathological classification was based on the Dallas cri-
teria [10] and proved an active inflammatory process in twelve of
the patients, with myocarditis defined as myocardial necrosis,
degeneration, or both, in the absence of significant coronary ar-
tery disease with an adjacent inflammatory infiltrate with or with-
out fibrosis. Borderline myocarditis was found in two remaining
patients (i.e.the inflammatory infiltrate too sparse or the myocyte
damage not apparent).
Heart scintigraphy with the use of 99mTc-Anti-Granulocyte BW
250/183 was performed in all patients using a double-head ga-
mma camera (E-Cam, Siemens, Erlangen, Germany) equipped
with high resolution collimators. A radiotracer of 740 MBq (20 mCi)
activity was given intravenously. Following the administration of
the radiotracer a 1 minute series of planar scans were performed
within the first 60 minutes. Delayed static scans were performed
at 1, 2, 4 and 24 hours. In ten of the fourteen patients, the
99mTc-Anti-granulocyte scintigraphy was repeated 3–5 months af-
ter the first study, when the control myocardial biopsy was nega-
tive (anti-inflammatory drugs were discontinued before that scin-
tigraphy). Three of the four patients not tested had not given their
consent to be examined, including the patient with a negative re-
sult from the first test, and one patient died.
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Results
The first scintigraphic scan revealed the uptake of the tracer
in the heart area in 13 patients, confirming an active inflammatory
process. The patients were diagnosed with myocarditis and treat-
ed accordingly with anti-inflammatory drugs. An increase of LVEF
(20–63%; mean value — 33 ± 13.2%) was noted in echocardio-
graphies in all patients. A check-up scintigraphy with the use of
99mTc-Anti-Granulocyte BW 250/183 was performed again in ten
patients after the resolution of all clinical symptoms of myocardi-
tis accompanied by negative results of a myocardial biopsy. The
scintigraphy revealed no abnormalities in nine of them and de-
tected the uptake of the tracer in the heart area in one patient, with
the accumulation of 99m-Anti-Granulocyte in the postero-inferior wall
of the heart. In the latter patient, the myocardial biopsy that was
negative had been taken from the anterior wall. A further scinti-
graphic examination performed three months later proved nega-
tive in this patient.
No hypersensitivity reactions after the intravenous injection of
99mTc-Anti-Granulocyte BW 250/183 were observed. Static scans
taken 1 and 2 hours following administration of the tracer did not
add any important information to the study. Delayed static scans
performed at 4 and 24 hours were found to be most useful. One
of the positive results of 99mTc-Anti-granulocyte BW 250/183 scin-
tigraphy is presented in Figure 1.
Discussion
It remains controversial whether myocardial biopsy should be
performed routinely in all cases of suspected myocarditis as it is
an invasive method carrying a risk of complications. We believe,
that scintigraphy with 99mTc-Anti-Granulocyte BW 250/183 is an
interesting method that is safe and accurate enough to be con-
sidered a screening tool for testing patients with suspected myo-
carditis before a decision on myocardial biopsy is made. It might
be of special value in those patients in whom traditional methods
have yielded equivocal data.
Many radiopharmaceuticals have been used so far to confirm
the inflammatory process in the heart: 67mGa, 99mTc-nanocolloid,
111In-leucocytes, 111In-Oxine, MIBG and autologic antibodies
against myosin labeled with 111In (111In-Mioscint — antimyosin
monoclonal antibody). Scintigraphy applied to the use of antimy-
osin monoclonal antibody has been a valuable and sensitive meth-
od in evaluating myocarditis [11, 12], but is no longer available as
111Indium-labeled antimyosin is not produced anymore due to
economic reasons. One of the antimyosin studies revealed myo-
carditis to be present in 10% of patients with unexplained myo-
carditis [13]. In certain cases of viral infection the inflammatory
process in the heart may not cause the damage of cardiomyo-
cytes. The results of scintigraphy with the use of antimyosin mono-
clonal antibody might therefore be negative in such cases re-
gardless the active inflammation.
The use of radiolabeled leukocyte scintigraphy is nowadays
a routine procedure in most nuclear medicine departments for
the investigation of different inflammatory pathologies involving
leukocytic infiltration [14–16]. It could be performed either by radio-
labeling white blood cells isolated from the patient which is
a very demanding procedure, or preferably by directly targeting
leukocyte antigens or receptors [7–9]. Agents which preferentially
bind to granulocytes are most suitable for visualising the site of
acute inflammation. The most widely used and described one is
LeukoScan (with 99mTc-labeled monoclonal antibody Fab’-frag-
ments) scintigraphy. The radiolabeled antibody molecule is small,
only a Fab’ fragment with one binding arm and devoid of the
immunogenic Fc portion of the immunoglobulin, and reactive with
a granulocyte surface antigen, NCA90 [16]. There are numerous
Figure 1. Positive result of two-dimensional scintigraphy with 99mTc-Anti-Granulocyte BW 250/183. The scintigraphy revealed accumulation of the tracer in
cardiac area. A. Anterior view; B. LAO45 view.
A B
168
Nuclear Medicine Review 2004, Vol. 7, No. 2
www.nmr.viamedica.pl
Short
communi-
cations
reports in medical journals of the usefulness of this marker in the
diagnosis of various inflammatory processes most often in bones
and joints [18, 19], as well as in abdominal tissues and of its use
in seeking unknown source of infection [20]. In heart studies, this
marker has successfully been used to confirm the inflammation
localised in heart valves and around the endomyocardial elec-
trode — pacemaker electrode tip infection [17]; and has proved
useful in confirming inflammatory infiltration after transmyocardial
laser revascularisation (TMLR). There is not much data available
so far on the application of this marker in the diagnosis [21] and
monitoring of myocarditis.
The tracer we used in the study — 99mTc-Anti-Granulocyte BW
250/183 (99mTc-labeled monoclonal CEA-NCA specific antibody)
is another marker employed in the diagnosis of inflammatory pro-
cesses. It is similar to LeucoScan and easy to prepare compared
with previously the most often used autologic leukocytes labeled
with 111In. It reacts with more than 90% of granulocytes in the pe-
ripheral blood as well as with granulocytes in the bone marrow
but does not impair granulocyte function, and the investigation
has no effect on blood granulocyte count. The indications for the
use of this radiolabeled molecule include immunoscintigraphy of
inflammation (including the skeleton, the intestinal tract and other
soft tissues and organs) and immunoscintigraphy of red bone
marrow. The results of our study showed this method to be sensi-
tive in determining myocarditis compared with the results of myo-
cardial biopsy. We believe it might also be used to monitor the
severity and extent of an inflammatory process in the heart with-
out the need of further control biopsies. Nevertheless further studies
involving greater numbers of patients are needed before definite
conclusions can be drawn and new clinical recommendations
made. Further indications for the test should be searched for, and
if its high sensitivity is confirmed it might also be considered in
evaluating patients with clinical presentation of myocardial infarc-
tion and normal coronary angiograms if myocarditis is suspected
[22–23]. Another group of patients that could benefit from this
test are those with vague clinical symptoms of myocarditis, which
might be obscured by the presence of severe coronary artery di-
sease [24].The wider use and usefulness of this technique is yet to be
established by further carefully planned studies recruiting patients
in whom scintigraphy with 99mTc-Anti-Granulocyte BW 250/183
could help in establishing the diagnosis and therefore improve
outcomes.
Conclusions
The results of the study showed the concordance between
myocardial biopsy and scintigraphy results in patients with an in-
flammatory process in the heart. Therefore, scintigraphy with the
use of 99mTc-Anti-Granulocyte seems to be a useful diagnostic
method in evaluating patients with suspected myocarditis, but
further studies are needed to assess its sensitivity and specificity.
An additional aim of the study was to establish an optimal
acquisition procedure in scintigraphic studies using 99mTc-Anti-
-Granulocyte antibody in the evaluation of the heart. Based on our
results, it seems to be indicated that delayed static scans should
be performed after 4 and 24 hours following the administration of
the tracer. Performing both planar and SPECT techniques of data
acquisition is most useful in providing scans yielding the most
accurate interpretation. The wider use and usefulness of this tech-
nique is yet to be established by further carefully planned studies
recruiting patients in whom scintigraphy with 99mTc-Anti-Granulo-
cyte BW 250/183 antibody could facilitate diagnosis and there-
fore improve outcomes.
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